إسرائيل - العبرية - Ministry of Health

cts chemical industries ltd, israel - ursodeoxycholic acid - טבליה - ursodeoxycholic acid 100 mg - ursodeoxycholic acid - ursodeoxycholic acid - dissolution or reductin in size of radiolucent cholesterol in patient with a functioning gallbladder. treatment of chronic liver diseases including primary billiary cirrhosis, primary sclerosing cholangitis, cystic fibrosis associated liver disease, biliary atresia, chronic hepatitis, and alcohol cirrhosis.

إسرائيل - العبرية - Ministry of Health

rafa laboratories ltd - ursodeoxycholic acid - קפסולות - ursodeoxycholic acid 250 mg - ursodeoxycholic acid - ursodeoxycholic acid - treatment of chronic liver diseases primary biliary cirrhosis & primary sclerosing cholangitis.

إسرائيل - العبرية - Ministry of Health

rafa laboratories ltd - ursodeoxycholic acid - טבליות מצופות פילם - ursodeoxycholic acid 500 mg - ursodeoxycholic acid - ursodeoxycholic acid - for the symptomatic treatment of primary biliary cirrhosis (pbc), in patients without decompensated hepatic cirrhosis.

إسرائيل - العبرية - Ministry of Health

novartis israel ltd - hydrochlorothiazide; valsartan - טבליות מצופות פילם - valsartan 80 mg; hydrochlorothiazide 12.5 mg - valsartan and diuretics - valsartan and diuretics - co-diovan is indicated for the treatment of hypertension for patients in whom combination therapy is appropriate.

إسرائيل - العبرية - Ministry of Health

novartis israel ltd - hydrochlorothiazide; valsartan - טבליות מצופות פילם - valsartan 160 mg; hydrochlorothiazide 12.5 mg - valsartan and diuretics - valsartan and diuretics - co-diovan is indicated for the treatment of hypertension in patients whose blood pressure is not adequately controlled by monotherapy. this fixed combination should be used as second-line therapy.

إسرائيل - العبرية - Ministry of Health

novartis israel ltd - hydrochlorothiazide; valsartan - טבליות מצופות פילם - valsartan 160 mg; hydrochlorothiazide 25 mg - valsartan and diuretics - valsartan and diuretics - co-diovan is indicated for the treatment of hypertension in patients whose blood pressure is not adequately controlled by monotherapy. this fixed combination should be used as second-line therapy.

إسرائيل - العبرية - Ministry of Health

masrouji company ltd - cefazolin as sodium 500 mg/vial - powder for solution for injection - cefazolin - treatment of serious infections caused by susceptible organisms and also perioperatively for prophylaxis. treatment respiratory tract: respiratory tract infections due to streptococcus pneumoniae (formerly diplococcus pneumoniae) klebsiella species haemophilus influenzae staphylococcus aureus (penicillin-sensitive and penicillin-resistant) and group a b - hemolytic streptococci. cefazolin is effective in the eradication of streptococci from the nasopharynx. however data establishing the efficacy of cefazolin in the subsequent prevention of rheumatic fever are not available at present. urinary tract: infections due to escherichia coli klebsiella species proteus mirabilis and some strains of enterobacter and enterococci. skin and skin structure: -hemolytic beta infections due to staphylococcus aureus (penicillin-sensitive and penicillin-resistant) group a streptococci and other strains of streptococci. biliary tract: infections due to escherichia coli various strains of streptococci proteus mirabilis klebsiella

إسرائيل - العبرية - Ministry of Health

novartis israel ltd - cefazolin as sodium - אבקה להכנת תמיסה לזריקה - cefazolin as sodium 1 g/vial - cefazolin - cefazolin - treatment of serious infections caused by susceptible organisms and also perioperatively for prophylaxis. treatment respiratory tract: respiratory tract infections due to streptococcus pneumoniae (formerly diplococcus pneumoniae) klebsiella species haemophilus influenzae staphylococcus aureus (penicillin-sensitive and penicillin-resistant) and group a b - hemolytic streptococci. cefazolin is effective in the eradication of streptococci from the nasopharynx. however data establishing the efficacy of cefazolin in the subsequent prevention of rheumatic fever are not available at present. urinary tract: infections due to escherichia coli klebsiella species proteus mirabilis and some strains of enterobacter and enterococci. skin and skin structure: -hemolytic beta infections due to staphylococcus aureus (penicillin-sensitive and penicillin-resistant) group a streptococci and other strains of streptococci. biliary tract: infections due to escherichia coli various strains of streptococci proteus mirabilis klebsiella

إسرائيل - العبرية - Ministry of Health

pharmalogic ltd - ceftriaxone as sodium - אבקה להמסה להזרקה\אינפוזיה - ceftriaxone as sodium 1 g/vial - ceftriaxone - ceftriaxone - treatment of infections caused by pathogens sensitive to ceftriaxone, e.g.: sepsis, meningitis, abdominal infections (peritonitis, infection of the biliary and gastrointestinal tract), infections of the bones, loints, soft tissue, skin and of wounds, infections in patients with impaired defense mechanisms, renal and urinary tract infections, respiratory tract infections, particularly pneumonia, and ear, nose and throat infections, genital infections including gonorrhea. perioperative prophylaxis of infections.

إسرائيل - العبرية - Ministry of Health

abic ltd. - diclofenac sodium 78.75 mg / 3 ml - solution for injection - diclofenac - treatment of: - exacerbations of inflammatory and degenerative forms of rheumatism: rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, spondylarthritis, non-articular rheumatism.- treatment of painful conditions due to inflammation of non rheumatic origin.- renal colic and biliary colic - post-traumatic and post-operative pain, inflammation and swelling